Lower expression of Bax predicts poor clinical outcome in patients with glioma after curative resection and radiotherapy/chemotherapy

BACKGROUND: The prognosis in patients with gliomas after surgical resection followed by radiotherapy and/or chemotherapy is still very poor. The pro-apoptotic protein Bax, a short-lived protein in cancers, plays important roles in the sensitivity of glioma cells to spontaneous and therapy-induced ap...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Pei-Guo, Li, Yu-Ting, Pan, Yi, Gao, Zhen-Zhu, Guan, Xu-Wen, Jia, Li, Liu, Feng-Ting
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer US 2018
Materias:
Laboratory Investigation
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6341054/
https://www.ncbi.nlm.nih.gov/pubmed/30446901
http://dx.doi.org/10.1007/s11060-018-03031-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6341054/
https://www.ncbi.nlm.nih.gov/pubmed/30446901
http://dx.doi.org/10.1007/s11060-018-03031-9

Ejemplares similares